Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients' perspective.
Eur J Cancer
; 136: 132-139, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-656548
ABSTRACT
BACKGROUND:
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, has inevitable consequences for medical care of patients without COVID-19. To assess the impact of this pandemic on oncological care, a nationwide survey was conducted among patients with cancer in the Netherlands.METHODS:
The patients' perspective on oncological care was investigated using an online survey between March 29th 2020 and April 18th 2020. The survey consisted of 20 questions on four topics patients' characteristics, contact with the hospital, consequences of the COVID-19 pandemic and concerns about COVID-19.RESULTS:
Five thousand three hundred two patients with cancer completed this nationwide survey. Overall, 30% of patients reported consequences for their oncological treatment or follow-up. In the majority of cases, this resulted in conversion from hospital visit to consultation by phone or video. The most frequently adjusted treatments were chemotherapy (30%) and immunotherapy (32%). Among patients with delay and discontinuation of treatment, 55% and 63% of patients, respectively, were (very) concerned about these consequences of the COVID-19 pandemic. Consequences were independent of regional differences in COVID-19 incidence. However, patients in regions with high COVID-19 incidence were significantly more concerned.CONCLUSION:
This is the first study investigating perspectives of patients with cancer during the COVID-19 pandemic. The study demonstrates the significant impact of the COVID-19 crisis on oncological care, indicating the need for psycho-oncological support during this pandemic.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Attitude to Health
/
Telemedicine
/
Coronavirus Infections
/
Time-to-Treatment
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
/
Qualitative research
/
Randomized controlled trials
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
English
Journal:
Eur J Cancer
Year:
2020
Document Type:
Article
Affiliation country:
J.ejca.2020.06.019
Similar
MEDLINE
...
LILACS
LIS